相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A complex interplay between Akt, TSC2 and the two mTOR complexes
Jingxiang Huang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Phosphoinositide 3-kinases in cell migration
Robert J. Cain et al.
BIOLOGY OF THE CELL (2009)
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment
Ken Inoki et al.
HUMAN MOLECULAR GENETICS (2009)
Coordination of Rho GTPase activities during cell protrusion
Matthias Machacek et al.
NATURE (2009)
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2
Jingxiang Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways
L. Liu et al.
ONCOGENE (2006)
FilGAP, a Rho- and ROCK-regulated GAP for Rac binds filamin A to control actin remodelling
Yasutaka Ohta et al.
NATURE CELL BIOLOGY (2006)
To stabilize neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the back as well as signals at the front
Alexandra Van Keymeulen et al.
JOURNAL OF CELL BIOLOGY (2006)
Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly
Fukun Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Racl-null mouse embryonic fibroblasts are motile and respond to platelet-derived growth factor
L Vidali et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2
BD Manning et al.
GENES & DEVELOPMENT (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase
E Goncharova et al.
JOURNAL OF CELL BIOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis
BD Manning
JOURNAL OF CELL BIOLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Targeting mTOR signaling for cancer therapy
S Huang et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration
A Astrinidis et al.
ONCOGENE (2002)
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
AR Tee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity
WT Arthur et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCζ
S Etienne-Manneville et al.
CELL (2001)
The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
RF Lamb et al.
NATURE CELL BIOLOGY (2000)
分享论文
